Trial Profile
A Phase 1, Randomized, Double-blind, Placebo-controlled, Single Ascending Dose Study to Evaluate the Safety and Tolerability of LPT99 Administered to Healthy Adult Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 19 Mar 2020
Price :
$35
*
At a glance
- Drugs LPT 99 (Primary)
- Indications Hearing loss
- Focus Adverse reactions
- Sponsors Spiral Therapeutics
- 26 Feb 2020 Status changed from active, no longer recruiting to completed.
- 22 Aug 2019 Planned End Date changed from 9 Apr 2019 to 20 Sep 2019.
- 22 Aug 2019 Status changed from recruiting to active, no longer recruiting.